Treatment Satisfaction and Quality of Life with Tirzepatide Versus Dulaglutide Among Japanese Patients with Type 2 Diabetes: Exploratory Evaluation of the SURPASS J-mono Trial

por Ishii, Hitoshi, Oura, Tomonori, Takeuchi, Masakazu
Publicado 2023

An Exploration of Barriers to Insulin Initiation for Physicians in Japan: Findings from the Diabetes Attitudes, Wishes and Needs (DAWN) JAPAN Study

por Ishii, Hitoshi, Iwamoto, Yasuhiko, Tajima, Naoko
Publicado 2012

Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol

por Ishii, Hitoshi, Suzaki, Yuki, Miyata, Yuko
Publicado 2017

Development of the Well-being questionnaire short-form in Japanese: the W-BQ12

por Riazi, Afsane, Bradley, Clare, Barendse, Shalleen, Ishii, Hitoshi
Publicado 2006

Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4...

por Ishii, Hitoshi, Suzaki, Yuki, Miyata, Yuko, Matsui, Shingo
Publicado 2019

Once-Weekly Dulaglutide with Insulin Therapy for Type 2 Diabetes: Efficacy and Safety Results from a Phase 4, Randomized, Placebo-Controlled Study

por Ishii, Hitoshi, Onishi, Yukiko, Oura, Tomonori, Takeuchi, Masakazu
Publicado 2019

Efficacy and Safety of Once-Weekly Dulaglutide in Type 2 Diabetes Patients Using Insulin: Exploratory Subgroup Analysis by Insulin Regimen

por Onishi, Yukiko, Ishii, Hitoshi, Oura, Tomonori, Takeuchi, Masakazu
Publicado 2020

CIME Summer School

por Achdou, Yves, Barles, Guy, Ishii, Hitoshi, Litvinov, Grigory L
Publicado 2013

Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Contro...

por Ishii, Hitoshi, Hansen, Brian B., Langer, Jakob, Horio, Hiroshi
Publicado 2021

Higher levels of physical activity are independently associated with a lower incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: A prospective cohort study...

por Kuwata, Hirohito, Okamura, Shintaro, Hayashino, Yasuaki, Tsujii, Satoru, Ishii, Hitoshi
Publicado 2017

Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled...

por Ishii, Hitoshi, Hayashino, Yasuaki, Akai, Yasuhiro, Yabuta, Matahiro, Tsujii, Satoru
Publicado 2017

Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin‐changing study intending to gain patients' insigh...

por Ishii, Hitoshi, Terauchi, Yasuo, Jinnouchi, Hideaki, Taketsuna, Masanori, Takeuchi, Masakazu, Imaoka, Takeshi
Publicado 2013

Improvement of quality of life through glycemic control by liraglutide, a GLP-1 analog, in insulin-naive patients with type 2 diabetes mellitus: the PAGE1 study

por Ishii, Hitoshi, Niiya, Tetsuji, Ono, Yasuhiro, Inaba, Naoyuki, Jinnouchi, Hideaki, Watada, Hirotaka
Publicado 2017

Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes

por Ishii, Hitoshi, Takamura, Hiroshi, Nishioka, Yuichi, Langer, Jakob, Watanabe, Michihisa, Kim, Hyunchung Ray, Crawford, Bruce
Publicado 2020

The Influence of Sitagliptin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus Receiving Insulin Treatment: A Prespecified Sub-Analysis

por Mita, Tomoya, Katakami, Naoto, Shiraiwa, Toshihiko, Yoshii, Hidenori, Gosho, Masahiko, Ishii, Hitoshi, Shimomura, Iichiro, Watada, Hirotaka
Publicado 2017

Incidence and seasonality of type 1 diabetes: a population-based 3-year cohort study using the National Database in Japan

por Nishioka, Yuichi, Noda, Tatsuya, Okada, Sadanori, Myojin, Tomoya, Kubo, Shinichiro, Higashino, Tsuneyuki, Ishii, Hitoshi, Imamura, Tomoaki
Publicado 2020

Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT...

por Ishii, Hitoshi, Nakajima, Hiroki, Kamei, Nozomu, Uchida, Daigaku, Suzuki, Daisuke, Ono, Yasuhiro, Sato, Yasunori, Shimono, Dai
Publicado 2021

Quality-of-Life Comparison of Dapagliflozin Versus Dipeptidyl Peptidase 4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (J-BOND Study)

por Ishii, Hitoshi, Nakajima, Hiroki, Kamei, Nozomu, Niiya, Tetsuji, Hiyoshi, Toru, Hiramori, Yuko, Ohtsu, Shigeyuki, Noto, Takashi, Shimono, Dai
Publicado 2020

Appropriate definition of diabetes using an administrative database: A cross‐sectional cohort validation study

por Nishioka, Yuichi, Takeshita, Saki, Kubo, Shinichiro, Myojin, Tomoya, Noda, Tatsuya, Okada, Sadanori, Ishii, Hitoshi, Imamura, Tomoaki, Takahashi, Yutaka
Publicado 2021

Association between dipeptidyl peptidase‐4 inhibitors and increased risk for bullous pemphigoid within 3 months from first use: A 5‐year population‐based cohort study using the Jap...

por Kuwata, Hirohito, Nishioka, Yuichi, Noda, Tatsuya, Kubo, Shinichiro, Myojin, Tomoya, Higashino, Tsuneyuki, Takahashi, Yutaka, Ishii, Hitoshi, Imamura, Tomoaki
Publicado 2021